ifosfamide has been researched along with Infection, Toxoplasma gondii in 1 studies
Excerpt | Relevance | Reference |
---|---|---|
"Our results found that Toxoplasma gondii infection in the brain increases SOCS3 expression and decreases the phosphorylation of STAT3, resulting in reducing IL-17A and IL-23, which suppress the differentiation and expansion of pathogenic Th17 cells, an important factor in MS development." | 1.62 | Chronic Toxoplasma gondii Infection Alleviates Experimental Autoimmune Encephalomyelitis by the Immune Regulation Inducing Reduction in IL-17A/Th17 Via Upregulation of SOCS3. ( Ham, DW; Kim, SG; Lee, SH; Seo, SH; Shin, EH; Shin, JH, 2021) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Ham, DW | 1 |
Kim, SG | 1 |
Seo, SH | 1 |
Shin, JH | 1 |
Lee, SH | 1 |
Shin, EH | 1 |
1 other study available for ifosfamide and Infection, Toxoplasma gondii
Article | Year |
---|---|
Chronic Toxoplasma gondii Infection Alleviates Experimental Autoimmune Encephalomyelitis by the Immune Regulation Inducing Reduction in IL-17A/Th17 Via Upregulation of SOCS3.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Brain; Cisplatin; Enceph | 2021 |